المؤلفون: D Hadzi Boskovic, E Wiggins, P Parab, JN Liberman

المصدر: Value in Health. 25:S583

مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6721edf33beacf85cfb1eb7e1f85c98f
https://doi.org/10.1016/j.jval.2022.04.1563

المؤلفون: C Teigland, S Kim, I Mohammadi, B Agatep, D Hadzi Boskovic

المصدر: Value in Health. 25:S455

مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4a243bf49e4f44280e4780d2ebbad2f0
https://doi.org/10.1016/j.jval.2022.04.864

المؤلفون: D Hadzi Boskovic, M Gorritz, M Yasuda, J He, CC Chen

المصدر: Value in Health. 25:S379

مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::acec02f58eeb048f04a1057467e219ff
https://doi.org/10.1016/j.jval.2022.04.480

المؤلفون: Hadzi Boskovic D; Global Value and Real World Evidence, Otsuka Pharmaceutical Development & Commercialization Inc, Princeton, NJ, USA., Smith-Palmer J; Covalence Research Ltd, Harpenden, Hertfordshire, UK., Pöhlmann J; Covalence Research Ltd, Harpenden, Hertfordshire, UK., Pollock RF; Covalence Research Ltd, Harpenden, Hertfordshire, UK., Hwang S; Global Value and Real World Evidence, Otsuka Pharmaceutical Development & Commercialization Inc, Princeton, NJ, USA., Bruhn D; Global Value and Real World Evidence, Otsuka Pharmaceutical Development & Commercialization Inc, Princeton, NJ, USA.

المصدر: Patient related outcome measures [Patient Relat Outcome Meas] 2024 Jun 17; Vol. 15, pp. 199-217. Date of Electronic Publication: 2024 Jun 17 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Dove Medical Press Ltd Country of Publication: New Zealand NLM ID: 101551170 Publication Model: eCollection Cited Medium: Print ISSN: 1179-271X (Print) Linking ISSN: 1179271X NLM ISO Abbreviation: Patient Relat Outcome Meas Subsets: PubMed not MEDLINE

المؤلفون: Hadzi Boskovic D; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA., Liang S; Health Analytics, LLC, Clarksville, MD, USA., Parab P; Health Analytics, LLC, Clarksville, MD, USA., Wiggins E; Health Analytics, LLC, Clarksville, MD, USA., Liberman JN; Health Analytics, LLC, Clarksville, MD, USA.

المصدر: ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2023 Jun 22; Vol. 15, pp. 487-498. Date of Electronic Publication: 2023 Jun 22 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101560564 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6981 (Print) Linking ISSN: 11786981 NLM ISO Abbreviation: Clinicoecon Outcomes Res Subsets: PubMed not MEDLINE

المؤلفون: Chopra AS; Manticore Consultancy, North Potomac, MD, USA., Hadzi Boskovic D; Otsuka Pharmaceutical Development and Commercialization, Princeton, NJ, USA., Kulkarni A; Otsuka Pharmaceutical Development and Commercialization, Princeton, NJ, USA., Cochran JM; Otsuka Pharmaceutical Development and Commercialization, Princeton, NJ, USA.

المصدر: ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2023 May 22; Vol. 15, pp. 375-386. Date of Electronic Publication: 2023 May 22 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101560564 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6981 (Print) Linking ISSN: 11786981 NLM ISO Abbreviation: Clinicoecon Outcomes Res Subsets: PubMed not MEDLINE

المؤلفون: Cohen EA; Hassman Research Institute, Marlton, New Jersey., Skubiak T; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey., Hadzi Boskovic D; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey., Norman K; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey., Knights J; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey., Fang H; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey., Coppin-Renz A; Otsuka Pharmaceutical Development & Commercialisation Europe GmbH, Hessen, Germany., Peters-Strickland T; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey., Lindenmayer JP; Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York., Reuteman-Fowler JC; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey.; Corresponding author: J. Corey Reuteman-Fowler, PhD, 38 Hewitt Rd, Lambertville, NJ 08530 (tarheel.phd@gmail.com).

المصدر: The Journal of clinical psychiatry [J Clin Psychiatry] 2022 Apr 11; Vol. 83 (3). Date of Electronic Publication: 2022 Apr 11.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Physicians Postgraduate Press Country of Publication: United States NLM ID: 7801243 Publication Model: Electronic Cited Medium: Internet ISSN: 1555-2101 (Electronic) Linking ISSN: 01606689 NLM ISO Abbreviation: J Clin Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Antipsychotic Agents*/adverse effects , Schizophrenia*/chemically induced , Schizophrenia*/drug therapy, Adult ; Hospitalization ; Humans ; Inpatients ; Prospective Studies ; Retrospective Studies ; Treatment Outcome